
Nancy Bitar
Examiner (ID: 11522, Phone: (571)270-1041 , Office: P/2669 )
| Most Active Art Unit | 2664 |
| Art Unit(s) | 2624, 2669, 2664 |
| Total Applications | 1250 |
| Issued Applications | 1011 |
| Pending Applications | 68 |
| Abandoned Applications | 193 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16569111
[patent_doc_number] => 20210008117
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => ADIPONECTIN-EXPRESSING REGULATORY T-CELL PRECURSORS, COMPOSITION AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/864774
[patent_app_country] => US
[patent_app_date] => 2020-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15694
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16864774
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/864774 | ADIPONECTIN-EXPRESSING REGULATORY T-CELL PRECURSORS, COMPOSITION AND METHODS THEREOF | Apr 30, 2020 | Pending |
Array
(
[id] => 16312619
[patent_doc_number] => 20200291357
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => METHODS AND PRODUCTS FOR TRANSFECTING CELLS
[patent_app_type] => utility
[patent_app_number] => 16/857894
[patent_app_country] => US
[patent_app_date] => 2020-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23412
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16857894
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/857894 | Methods and products for transfecting cells | Apr 23, 2020 | Issued |
Array
(
[id] => 17688170
[patent_doc_number] => 20220195462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => FULLY-HUMAN POST-TRANSLATIONALLY MODIFIED ANTIBODY THERAPEUTICS
[patent_app_type] => utility
[patent_app_number] => 17/605486
[patent_app_country] => US
[patent_app_date] => 2020-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 165198
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17605486
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/605486 | FULLY-HUMAN POST-TRANSLATIONALLY MODIFIED ANTIBODY THERAPEUTICS | Apr 23, 2020 | Pending |
Array
(
[id] => 19491811
[patent_doc_number] => 12110509
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-08
[patent_title] => Stem cell-derived Sertoli-like cell, preparation method therefor, and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/811086
[patent_app_country] => US
[patent_app_date] => 2020-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 23
[patent_no_of_words] => 7974
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16811086
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/811086 | Stem cell-derived Sertoli-like cell, preparation method therefor, and use thereof | Mar 5, 2020 | Issued |
Array
(
[id] => 19274603
[patent_doc_number] => 12024714
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-02
[patent_title] => Method for preparation of retinal ganglion cells
[patent_app_type] => utility
[patent_app_number] => 16/808170
[patent_app_country] => US
[patent_app_date] => 2020-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 55
[patent_no_of_words] => 19132
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16808170
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/808170 | Method for preparation of retinal ganglion cells | Mar 2, 2020 | Issued |
Array
(
[id] => 17642307
[patent_doc_number] => 20220170045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => AUGMENTATIONS TO LENTIVIRAL VECTORS (CCLC-MGATA/ANK-CORE LCR-BETA-AS3-FB) TO INCREASE EXPRESSION
[patent_app_type] => utility
[patent_app_number] => 17/433577
[patent_app_country] => US
[patent_app_date] => 2020-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13927
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17433577
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/433577 | AUGMENTATIONS TO LENTIVIRAL VECTORS (CCLC-MGATA/ANK-CORE LCR-BETA-AS3-FB) TO INCREASE EXPRESSION | Feb 26, 2020 | Pending |
Array
(
[id] => 16513283
[patent_doc_number] => 20200392541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => DELIVERY AND USE OF THE CRISPR-CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
[patent_app_type] => utility
[patent_app_number] => 16/800988
[patent_app_country] => US
[patent_app_date] => 2020-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 126749
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16800988
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/800988 | Delivery and use of the CRISPR-CAS systems, vectors and compositions for hepatic targeting and therapy | Feb 24, 2020 | Issued |
Array
(
[id] => 17719064
[patent_doc_number] => 20220211783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => GMCI AND DDRI COMBINATION THERAPY FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 17/610661
[patent_app_country] => US
[patent_app_date] => 2020-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6313
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17610661
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/610661 | GMCI AND DDRI COMBINATION THERAPY FOR TREATING CANCER | Feb 23, 2020 | Abandoned |
Array
(
[id] => 16539469
[patent_doc_number] => 20200405882
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => RECOMBINANT ADENO-ASSOCIATED VECTORS FOR TARGETED TREATMENT
[patent_app_type] => utility
[patent_app_number] => 16/787980
[patent_app_country] => US
[patent_app_date] => 2020-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17132
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16787980
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/787980 | Recombinant adeno-associated vectors for targeted treatment | Feb 10, 2020 | Issued |
Array
(
[id] => 15993983
[patent_doc_number] => 20200172862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => METHODS FOR DIFFERENTIATING PLURIPOTENT CELLS
[patent_app_type] => utility
[patent_app_number] => 16/782772
[patent_app_country] => US
[patent_app_date] => 2020-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23370
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -74
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16782772
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/782772 | METHODS FOR DIFFERENTIATING PLURIPOTENT CELLS | Feb 4, 2020 | Pending |
Array
(
[id] => 15931741
[patent_doc_number] => 20200157504
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => METHODS AND PRODUCTS FOR TRANSFECTING CELLS
[patent_app_type] => utility
[patent_app_number] => 16/776765
[patent_app_country] => US
[patent_app_date] => 2020-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23447
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16776765
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/776765 | Methods and products for transfecting cells | Jan 29, 2020 | Issued |
Array
(
[id] => 15963637
[patent_doc_number] => 20200165570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => METHODS FOR REPROGRAMMING CELLS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/752462
[patent_app_country] => US
[patent_app_date] => 2020-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54468
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 198
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16752462
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/752462 | METHODS FOR REPROGRAMMING CELLS AND USES THEREOF | Jan 23, 2020 | Abandoned |
Array
(
[id] => 18718104
[patent_doc_number] => 11795439
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-24
[patent_title] => Methods for reprogramming cells and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/752535
[patent_app_country] => US
[patent_app_date] => 2020-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 30
[patent_no_of_words] => 63166
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 252
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16752535
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/752535 | Methods for reprogramming cells and uses thereof | Jan 23, 2020 | Issued |
Array
(
[id] => 17520722
[patent_doc_number] => 20220106571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => CHOROID PLEXUS ORGANOIDS AND METHODS FOR PRODUCTION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/425043
[patent_app_country] => US
[patent_app_date] => 2020-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21762
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17425043
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/425043 | Choroid plexus organoids and methods for production thereof | Jan 22, 2020 | Issued |
Array
(
[id] => 16107863
[patent_doc_number] => 20200205954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => METHODS FOR USE OF SEX SORTED SEMEN TO IMPROVE GENETIC MANAGEMENT IN SWINE
[patent_app_type] => utility
[patent_app_number] => 16/747406
[patent_app_country] => US
[patent_app_date] => 2020-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21113
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16747406
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/747406 | Methods for use of sex sorted semen to improve genetic management in swine | Jan 19, 2020 | Issued |
Array
(
[id] => 17292476
[patent_doc_number] => 20210388315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => ISOLATION AND CULTIVATION OF MUSCLE AND FAT CELLS FROM CRUSTACEANS
[patent_app_type] => utility
[patent_app_number] => 17/422596
[patent_app_country] => US
[patent_app_date] => 2020-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6156
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17422596
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/422596 | ISOLATION AND CULTIVATION OF MUSCLE AND FAT CELLS FROM CRUSTACEANS | Jan 12, 2020 | Abandoned |
Array
(
[id] => 16435686
[patent_doc_number] => 20200353011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => METHODS FOR MAKING AND USING SINOATRIAL NODE-LIKE PACEMAKER CARDIOMYOCYTES AND VENTRICULAR-LIKE CARDIOMYOCYTES
[patent_app_type] => utility
[patent_app_number] => 16/737768
[patent_app_country] => US
[patent_app_date] => 2020-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19558
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16737768
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/737768 | Methods for making and using sinoatrial node-like pacemaker cardiomyocytes and ventricular-like cardiomyocytes | Jan 7, 2020 | Issued |
Array
(
[id] => 17457879
[patent_doc_number] => 20220071183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => ANTHELMINTIC LABORATORY ANIMAL MODEL FOR HEARTWORM
[patent_app_type] => utility
[patent_app_number] => 17/417829
[patent_app_country] => US
[patent_app_date] => 2020-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10031
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17417829
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/417829 | ANTHELMINTIC LABORATORY ANIMAL MODEL FOR HEARTWORM | Jan 6, 2020 | Abandoned |
Array
(
[id] => 16238213
[patent_doc_number] => 20200255447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => THIENOPYRIMIDINES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/734892
[patent_app_country] => US
[patent_app_date] => 2020-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35283
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16734892
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/734892 | THIENOPYRIMIDINES AND USES THEREOF | Jan 5, 2020 | Abandoned |
Array
(
[id] => 15862937
[patent_doc_number] => 20200138872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => METHODS FOR COLLECTING AND USING PLACENTA CORD BLOOD STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 16/715597
[patent_app_country] => US
[patent_app_date] => 2019-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12541
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16715597
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/715597 | METHODS FOR COLLECTING AND USING PLACENTA CORD BLOOD STEM CELLS | Dec 15, 2019 | Abandoned |